These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34316727)

  • 1. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases.
    Hausmann JS; Kennedy K; Simard JF; Liew JW; Sparks JA; Moni TT; Harrison C; Larché MJ; Levine M; Sattui SE; Semalulu T; Foster G; Surangiwala S; Thabane L; Beesley RP; Durrant KL; Mateus EF; Mingolla S; Nudel M; Palmerlee CA; Richards DP; Liew DFL; Hill CL; Bhana S; Costello W; Grainger R; Machado PM; Robinson PC; Sufka P; Wallace ZS; Yazdany J; Sirotich E;
    Lancet Rheumatol; 2021 Oct; 3(10):e707-e714. PubMed ID: 34316727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.
    Sattui SE; Liew JW; Kennedy K; Sirotich E; Putman M; Moni TT; Akpabio A; Alpízar-Rodríguez D; Berenbaum F; Bulina I; Conway R; Singh AD; Duff E; Durrant KL; Gheita TA; Hill CL; Howard RA; Hoyer BF; Hsieh E; El Kibbi L; Kilian A; Kim AH; Liew DFL; Lo C; Miller B; Mingolla S; Nudel M; Palmerlee CA; Singh JA; Singh N; Ugarte-Gil MF; Wallace J; Young KJ; Bhana S; Costello W; Grainger R; Machado PM; Robinson PC; Sufka P; Wallace ZS; Yazdany J; Harrison C; Larché M; Levine M; Foster G; Thabane L; Rider LG; Hausmann JS; Simard JF; Sparks JA
    RMD Open; 2021 Sep; 7(3):. PubMed ID: 34493645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifications in Systemic Rheumatic Disease Medications: Patients' Perspectives During the Height of the COVID-19 Pandemic in New York City.
    Mancuso CA; Duculan R; Jannat-Khah D; Barbhaiya M; Bass AR; Mandl LA; Mehta B
    Arthritis Care Res (Hoboken); 2021 Jun; 73(6):909-917. PubMed ID: 33085850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Gianfrancesco M; Hyrich KL; Al-Adely S; Carmona L; Danila MI; Gossec L; Izadi Z; Jacobsohn L; Katz P; Lawson-Tovey S; Mateus EF; Rush S; Schmajuk G; Simard J; Strangfeld A; Trupin L; Wysham KD; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Machado PM; Robinson PC;
    Ann Rheum Dis; 2020 Jul; 79(7):859-866. PubMed ID: 32471903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial.
    Hanberg JS; Fu X; Wang X; Patel NJ; Kawano Y; Schiff A; Kowalski EN; Cook CE; Vanni KMM; Guzzo K; Qian G; Bade KJ; Saavedra A; Venkat R; Srivatsan S; Zhang Y; Sparks JA; Wallace ZS
    Lancet Rheumatol; 2024 Jan; 6(1):e21-e30. PubMed ID: 38258675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early impacts of the COVID-19 pandemic on children with pediatric rheumatic diseases.
    Hausmann JS; Kennedy K; Surangiwala S; Larche MJ; Sinha R; Durrant K; Foster G; Levine M; Thabane L; Costello W; Robinson PC; Liew JW; Yazdany J; Sirotich E
    Eur J Rheumatol; 2022 Oct; 9(4):185-190. PubMed ID: 35156622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance.
    Bermas BL; Gianfrancesco M; Tanner HL; Seet AM; Aguiar MC; Al Adhoubi NK; Al Emadi S; Cunha BM; Flood R; Kusevich DA; McCarthy EM; Patel NJ; Ruderman EM; Sattui SE; Sciascia S; Siddique F; Valenzuela-Almada MO; Wise LM; Worthing AB; Zell J; Bhana S; Costello W; Duarte-Garcia A; Grainger R; Gossec L; Hausmann JS; Hyrich K; Lawson-Tovey S; Liew JW; Sirotich E; Sparks JA; Sufka P; Wallace ZS; Machado PM; Strangfeld A; Clowse MEB; Yazdany J; Robinson PC
    J Rheumatol; 2022 Jan; 49(1):110-114. PubMed ID: 34470798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
    Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Cardenas-de la Garza JA; Gonzalez-Gonzalez V; Beltran-Aguilar VM; Arias-Peralta AG; De Avila-Gonzalez N; Guajardo-Jauregui N
    Clin Rheumatol; 2023 Oct; 42(10):2677-2690. PubMed ID: 36627529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
    Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
    Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
    Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
    Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
    Metyas S; Chen C; Aung T; Ballester A; Cheav S
    Curr Rheumatol Rev; 2022; 18(4):346-351. PubMed ID: 35152867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omicron variant infection in inflammatory rheumatological conditions - outcomes from a COVID-19 naive population in Aotearoa New Zealand.
    Brooks J; Montgomery A; Dalbeth N; Sapsford M; Ngan Kee R; Cooper A; Quincey V; Bhana S; Gore-Massy M; Hausmann J; Liew J; Machado PM; Sufka P; Sirotich E; Robinson P; Wallace Z; Yazdany J; Grainger R
    Lancet Reg Health West Pac; 2023 Sep; 38():100843. PubMed ID: 37520279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt.
    Gheita TA; Salem MN; Eesa NN; Khalil NM; Gamal NM; Noor RA; Moshrif AH; Shereef RE; Ismail F; Noshy N; Fawzy RM; Elshebini E; Khalifa I; Saadany HE; Tharwat S; El-Najjar A; Fattah YA; Sallam R; El-Bahnasawy AS; Gharbia O; Hassan E; ElShanawany A; Mohamed EF; Senara S; Ismail M; Nasef SI; Abdalla AM; Elessawi D; Fawzy SM; Alfadl EA; Khalifa A; Abaza NM;
    Rheumatol Int; 2020 Oct; 40(10):1599-1611. PubMed ID: 32710198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
    Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
    Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational Study.
    Michaud K; Pedro S; Wipfler K; Agarwal E; Katz P
    Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1322-1331. PubMed ID: 33787086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Kihara M; Sugihara T; Asano J; Sato M; Kaneko H; Muraoka S; Ohshima S; Nanki T
    Clin Rheumatol; 2022 Dec; 41(12):3661-3673. PubMed ID: 35974224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry.
    Gianfrancesco MA; Leykina LA; Izadi Z; Taylor T; Sparks JA; Harrison C; Trupin L; Rush S; Schmajuk G; Katz P; Jacobsohn L; Hsu TY; D'Silva KM; Serling-Boyd N; Wallwork R; Todd DJ; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Machado PM; Robinson PC; Yazdany J;
    Arthritis Rheumatol; 2021 Mar; 73(3):374-380. PubMed ID: 33146001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographical variations in COVID-19 perceptions and patient management: a national survey of rheumatologists.
    Mehta B; Jannat-Khah D; Mancuso CA; Bass AR; Moezinia CJ; Gibofsky A; Goodman SM; Ibrahim S
    Semin Arthritis Rheum; 2020 Oct; 50(5):1049-1054. PubMed ID: 32911282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient perspectives on telemedicine use in rheumatology during the COVID-19 pandemic: survey results from the COVID-19 Global Rheumatology Alliance.
    Maheswaranathan M; Miller B; Ung N; Sinha R; Harrison C; Egeli BH; Degirmenci HB; Sirotich E; Liew JW; Grainger R; Chock EY
    Clin Rheumatol; 2024 Jan; 43(1):543-552. PubMed ID: 37552351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.